Related Experiment Video
Updated: Jun 28, 2025
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
1.6K
Side branch predilatation during percutaneous coronary bifurcation intervention: Long-term mortality analysis
Dobrin Vassilev1,2, Niya Mileva1,3, Panayot Panayotov1,4
1Medica Cor Hospital, Ruse, Bulgaria.
Kardiologia Polska
|April 19, 2024
Summary
Side branch predilatation (SBPD) during coronary bifurcation interventions is linked to increased mortality. This study found SBPD is associated with worse patient survival, despite better angiographic results.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Current guidelines do not recommend side branch predilatation (SBPD) for coronary bifurcation interventions.
- Limited data exists on the long-term clinical outcomes associated with SBPD.
Purpose of the Study:
- To investigate the association between SBPD and long-term mortality following coronary bifurcation interventions.
- To evaluate patient survival rates in relation to SBPD use.
Main Methods:
- A prospective registry of patients undergoing percutaneous coronary intervention for coronary bifurcation stenoses was utilized.
- Propensity score matching was employed to create comparable groups of patients with and without SBPD.
- Kaplan-Meier analysis and log-rank tests assessed mortality differences between groups.
Main Results:
- After propensity score matching, 648 patients (324 per group) were analyzed.
- Patients who underwent SBPD exhibited higher rates of all-cause mortality (33% vs. 30.2%) and cardiovascular mortality (25.3% vs. 21.6%) at a median 57-month follow-up.
- SBPD was identified as an independent predictor of both all-cause and cardiovascular mortality.
Conclusions:
- SBPD for coronary bifurcation stenoses is associated with poorer patient survival up to 8 years post-intervention.
- While SBPD may improve angiographic outcomes, these benefits do not translate to improved long-term clinical outcomes or survival.
